GPhA’s Drug Shortage Initiative Clears FTC Hurdle; Still Working With FDA
This article was originally published in The Gold Sheet
Executive Summary
Five manufacturers have agreed to give IMS Health production and supply information about drugs in short supply; GPhA and IMS are working with FDA to finalize the details of the accelerated recovery initiative.